RUN vs SPRO · P/E 6.0, rev $2.04B vs P/E 9.6, rev $48.0M
Sunrun Inc (RUN) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
RUN currently screens at market cap $3.05B and trailing P/E 6.0. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the RUN and SPRO stock pages for the full models.
Not investment advice.